National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance
A new framework can be used to compare influenza surveillance systems qualitatively between countries to allow the identification of structural differences as well as to evaluate adherence to WHO guidance. The framework may be adapted for other infectious
Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return
Due to non-pharmaceutical intervention measures the global influenza burden decreased substantially; but with lifting of restrictions a rebound in other respiratory virus pathogens is both plausible and likely.
Infectious diseases and cognition: do we have to worry?
Age-related physiological changes, particularly immune system decline, may contribute to greater vulnerability to infectious diseases in older individuals.
“Flu, COVID and RSV: How to vaccinate?” symposium at Options XI
Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination
Global influenza circulation has been heavily suppressed by public health measures and travel restrictions since the onset of the COVID-19 pandemic.
|
ESWI Airborne: Meet the Members
Spotlight on the burden of flu for people living with diabetes
Why are people with diabetes more at risk from flu? What are the options for reducing the risk? What are the challenges and solutions to increase awareness across health care professionals, researchers and patients themselves?
Project FluCov: understanding and communicating the impact of COVID-19 on influenza activity
Nivel is researching the impact of COVID-19 on Influenza activity combining data from around the world.
Big study reveals increased heart disease and diabetes risk after COVID-19
Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK
World Influenza Conference
September 17-18 2022, Shenzen China - Virtual
|
ESWI Airborne: Meet the Members
Flu shots for children? Why this should be more on the radar
ESWI Board Member Terho Heikkinen, Professor in paediatrics at the University of Turku in Finland talks about paediatric infectious diseases. Learn about why the flu shot is to be recommended in children.
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
High-dose influenza vaccines provide better protection against influenza infection than standard-dose in persons aged 65 years and above.